The fiscal year of Pfizer, Inc. ended on September 30, 2019. The company started its development stage of a project to produce a new drug on January 1, 2019. Expenses of $15, 000 per month were incurred until the project was completed on June 30, 2019 when the drug went into immediate production. It was on March 1, 2019 that the human testing became successful. The drug has an estimated life span of six years. What amount will the company charge to profit or loss for development costs including amortization for the fiscal year ended September 30, 2019?